Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue

Citation
Ja. Williams et al., Metabolic activation of carcinogens and expression of various cytochromes P450 in human prostate tissue, CARCINOGENE, 21(9), 2000, pp. 1683-1689
Citations number
53
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CARCINOGENESIS
ISSN journal
01433334 → ACNP
Volume
21
Issue
9
Year of publication
2000
Pages
1683 - 1689
Database
ISI
SICI code
0143-3334(200009)21:9<1683:MAOCAE>2.0.ZU;2-W
Abstract
Epidemiological evidence suggests a link between meat consumption and prost ate cancer. In this study, benign prostatic hyperplasia tissues, obtained b y transurethral resection or radical retropubic prostatectomy from UK-resid ent individuals (n = 18), were examined for CYP1 expression and for their a bility, in short-term organ culture, to metabolically activate carcinogens found in cooked meat. Semi-quantitative RT-PCR analysis of CYP1 expression detected CYP1A2 mRNA transcripts in the prostates of four individuals, as w ell as mRNA transcripts from CYP1A1 and CYP1B1, The compounds tested for me tabolic activation were 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (Ph IP; 500 mu M, n = 9) and its metabolite N-hydroxy PhIP (20 mu M, n = 8), 2- amino-3-methylimidazo[4,5-f]quinoline (IQ; 500 mu M, n = 6) and benzo[a]pyr ene (B[a]P; 50 mu M, n = 5), After incubation (PFMR medium, 22 h, 37 degree s C), DNA was isolated from tissue fragments and DNA adducts were detected and quantified by P-32-postlabelling analysis. DNA adduct formation was det ected in all samples incubated with PhIP (mean, adducts per 10(8) nucleotid es), N-hydroxy-PhIP (2736/10(8)) or B[a]P (1/10(8)), IQ-DNA adducts were de tected in 5/6 tissues (mean, 1/10(8)). The CYP1 inhibitor alpha-naphthoflav one (10 mu M) reduced B[a]P-DNA adduct formation in tissues from two indivi duals by 96 and 64%, respectively. This pilot study shows that human prosta te tissue can metabolically activate 'cooked meat' carcinogens, a process t hat could contribute to prostate cancer development.